BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26239614)

  • 1. MicroRNA-205 inhibits the proliferation and invasion of breast cancer by regulating AMOT expression.
    Zhang H; Fan Q
    Oncol Rep; 2015 Oct; 34(4):2163-70. PubMed ID: 26239614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomotin promotes breast cancer cell proliferation and invasion.
    Lv M; Lv M; Chen L; Qin T; Zhang X; Liu P; Yang J
    Oncol Rep; 2015 Apr; 33(4):1938-46. PubMed ID: 25647626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
    Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
    Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid raft-mediated miR-3908 inhibition of migration of breast cancer cell line MCF-7 by regulating the interactions between AdipoR1 and Flotillin-1.
    Li Y; Shan F; Chen J
    World J Surg Oncol; 2017 Mar; 15(1):69. PubMed ID: 28327197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
    Li S; Xu JJ; Zhang QY
    Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
    Wang CZ; Yuan P; Li Y
    Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
    Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
    Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
    Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
    Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiomotin-p130 inhibits β-catenin stability by competing with Axin for binding to tankyrase in breast cancer.
    Yang J; Zhang X; Chen Z; Shen Y; Wang F; Wang Y; Liu Y; Liu P; Yang J
    Cell Death Dis; 2019 Feb; 10(3):179. PubMed ID: 30792381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
    Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
    BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
    Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M
    PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
    Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.